Florida Node of The Drug Abuse Clinical Trials Network

药物滥用临床试验网络佛罗里达节点

• 批准号: 7686200
• 负责人: Jose Szapocznik
• 金额: $ 125万
• 依托单位: UNIVERSITY OF MIAMI SCHOOL OF MEDICINE
• 依托单位国家: 美国
• 财政年份: 2000
• 资助国家: 美国
• 起止时间: 2000-09-30 至 2010-08-31
• 项目状态: 已结题
• 来源: https://reporter.nih.gov/project-details/7686200
• 关键词: Accounting; Adolescent; Adoption; Adult; African American; Age; Clinical Trials Network; Collaborations; Combined Modality Therapy; Communication; County; Data Analyses; Doctor of Philosophy; Drug abuse; Ensure; Ethnic Origin; Family Study; Family psychotherapy; Florida; Funding; Gender; Government; Grant; HIV; Hereditary Disease; Hispanics; Intervention; Knowledge; Lead; Life; Methadone; Minority Groups; Modality; Multi-Institutional Clinical Trial; Nationalities; Patients; Pharmaceutical Preparations; Population; Population Heterogeneity; Primary Health Care; Progress Reports; Protocols documentation; Provider; Puerto Rico; Race; Research; Research Infrastructure; Research Personnel; Research Training; Resources; Risk Reduction; Running; Site; Social Work; Testing; Training; Trauma; Treatment Effectiveness; United States Virgin Islands; Universities; Woman; Work; adolescent substance abuse; base; behavioral pharmacology; caucasian American; community based treatment; design; dissemination trial; effectiveness trial; improved; medication compliance; meetings; named group; patient population; racial and ethnic

DESCRIPTION (provided by applicant): This is a competing continuation proposal for the Florida Node of NIDA's CTN. The aim of the Node is to develop and implement protocols that test the effectiveness of treatments across a broad range of community-based treatment settings with diverse patient populations, and to disseminate knowledge in a manner that improves the practice of drug abuse treatment in the Node, Puerto Rico and the nation. The partnership funded by this grant is led by the University of Miami-Center for Family Studies, with its considerable clinical trials, multi-site, HIV+, race/ethnicity, and drug abuse treatment expertise, serving as the Regional Research and Training Center (RRTC). The Florida Node governance represents strong bi-directional collaboration between the RRTC and CTPs. Collaborators in this partnership are five Florida CTPs that are among the largest and most respected in the State, representing the north (Gateway in Jacksonville), west (PAR in the Tampa/St Petersburg), East (Center for Drug Free Living in Orlando) and south (The Village in Miami; Spectrum in Broward County) parts of the State. Accounting for 45% of Florida's drug abuse treatment dollars, and with the capacity to serve 20,000 patients, these agencies offer exceptional diversity of treatment modalities, patient racial and ethnic profiles, and drug abusing and addicted populations. The Node also includes strong collaborative relationships with the Florida Single State Agency Director, the Florida ATTC, and the Florida provider association. As our progress report shows, the past 4 years have yielded major accomplishments in our work with these partners. Additionally, this proposal presents a number of ancillary relationships to expand the diversity of treatment settings, including primary care and social service settings represented by two large Miami-Dade County based primary care networks, a methadone treatment network, a government-run drug abuse treatment network, a close collaboration with the Puerto Rico and Virgin Islands ATTC, and a network of providers in Puerto Rico, among others. The infrastructure we have established over the past 4 years have allowed us to meet the challenges we had originally confronted (e.g., communication and collaboration across geographic distance) and have allowed us to successfully implement six CTN protocols including leading a large trial of family therapy for substance abusing adolescents, (CTN-0014), and co-leading the first ever multi-site effectiveness trial of drug abuse treatment with a Spanish-speaking population (CTN-0021). A concept, ideally suited for the CTN, proposes to test two strategies in the dissemination of an efficacious HIV intervention.

描述（由申请人提供）： 这是NIDA CTN佛罗里达节点的竞争延续建议。该节点的目的是制定和实施协议，以测试各种具有多种患者人群的社区治疗环境中治疗的有效性，并以改善节点，波多黎各和国家的药物滥用治疗的方式传播知识。该赠款资助的合作伙伴关系由迈阿密大学中心进行家庭研究，其临床试验，多站点，艾滋病毒+，种族/族裔和药物滥用治疗专业知识，作为区域研究与培训中心（RRTC）。佛罗里达节点治理代表RRTC和CTP之间的强大双向合作。该合作伙伴关系的合作者是五个佛罗里达州CTP，是该州最大，最受尊敬的CTP，代表北部（杰克逊维尔的盖特威），西部（位于坦帕/圣彼得堡的PAR），East（East（Orlando居住在奥兰多）和South（南方）和州（迈阿密的村庄; Broward County in Broward County in Stone; Spectrum in State; Spectrum in State; Spectrum in State; Spectrum;这些机构占佛罗里达州药物滥用治疗费用的45％，并为20,000名患者提供服务的能力，提供了特殊的治疗方式，患者种族和种族概况以及滥用和上瘾的人群。该节点还包括与佛罗里达州单一国家机构总监，佛罗里达ATTC和佛罗里达州提供商协会的牢固合作关系。正如我们的进度报告所示，过去4年在与这些合作伙伴的工作中取得了重大成就。 此外，该提案还提出了许多辅助关系，以扩大治疗环境的多样性，包括由两个大型迈阿密戴德县的初级保健网络代表的初级保健和社会服务环境，美沙酮治疗网络，政府运营的毒品滥用治疗网络，与波多黎各和维吉群岛ATTC以及Puerto in Puerto Rico的Puerto Rico和Virgin Islants ATTC的密切合作。 在过去的四年中，我们建立的基础架构使我们能够应对我们最初面临的挑战（例如，跨地理距离的沟通和协作），使我们能够成功实施六项CTN方案，包括领导家庭治疗的大规模试验，以滥用毒品，以滥用毒品，并与西班牙施加量的人群（CTN-0014），以及一项经验丰富的药物有效效果，以实现良好的效力，以实现良好的效力，以实现良好的效力，以实现良好的药物治疗。 （CTN-0021）。一个理想适合CTN的概念提议在传播有效的HIV干预措施中测试两种策略。